San Marcos, CA, United States of America

Brian Christopher Smith

This inventor holds 80 USPTO granted patents and 26 published patent applications, plus 9 CIPO patents and 10 EPO patents, primarily in Continuous Glucose Monitoring (CPC class A61B5-14532). Top assignees: Dexcom, Inc., Arena Pharmaceuticals, Inc., Other. Active years: 1985-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Christopher Smith. Retrieved from https://idiyas.com/inventor/brian-christopher-smith

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 80 

% Patents Active = 88.8

 

 

Average Co-Inventor Count = 6.1

ph-index = 19

Forward Citations = 1,144(Granted Patents)

Forward Citations (Not Self Cited) = 827(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Huntsville, AL (US) (1985)
  • San Diego, CA (US) (2005 - 2024)
  • San Marcos, CA (US) (2016 - 2024)

Company Filing History:


Years Active: 1985-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Continuous Glucose Monitoring
Wearable Devices
Health Data Visualization
Analyte Monitoring
User Interfaces
Wireless Communication
Alert Systems
Remote Monitoring
Bolus Calculator
Graphical User Interface
Mobile Communications
Data Presentation
80 patents (USPTO):Explore Patents

Title: Innovations by Brian Christopher Smith in Continuous Glucose Monitoring

Introduction

Brian Christopher Smith, an accomplished inventor based in San Marcos, CA, has made significant contributions to the field of continuous glucose monitoring technology. With a remarkable portfolio of 76 patents, Smith's innovations are pivotal in enhancing diabetes management through advanced monitoring systems.

Latest Patents

Among his latest patents are two groundbreaking inventions:

1. **Continuous Glucose Monitor Communication with Multiple Display Devices**

This invention focuses on a continuous glucose monitor that wirelessly transmits glucose value data to multiple display devices. It also outlines systems and methods for limiting the number of display devices that can connect to a continuous glucose transmitter. The invention emphasizes security measures, including hashing techniques and a changing application key, to ensure secure communications between the transmitter and displays.

2. **Wearable Apparatus for Continuous Blood Glucose Monitoring**

This patent involves a system and method for wearable continuous blood glucose monitoring. It encompasses a smartwatch that receives alerts representing a glucose state of a host-patient connected to a glucose sensor. Upon detecting a predetermined action, the smartwatch presents a glance view, indicating the glucose state of the user.

Career Highlights

Brian Christopher Smith has had an impactful career, working with leading companies such as Dexcom, Inc. and Arena Pharmaceuticals, Inc. His contributions in these roles have further advanced the technology surrounding diabetes management.

Collaborations

Throughout his career, Smith has collaborated with notable colleagues, including Eric Cohen and Katherine Yerre Koehler. Together, they have worked on various innovations in the field that have helped shape modern glucose monitoring systems.

Conclusion

Brian Christopher Smith continues to be a driving force in the innovation of continuous glucose monitoring technologies. His extensive patent portfolio reflects his dedication to improving the lives of individuals living with diabetes through cutting-edge solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…